Dyne Therapeutics Inc. (DYN)

NASDAQ: DYN · Real-Time Price · USD

12.03

0.24 (2.04%)

At close: May 01, 2025, 3:59 PM

Dyne Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-317.42M	-235.94M	-168.1M	-149.29M	-59.44M	-14.86M	-4.81M	76M	-1.24B
Depreciation & Amortization	-1.93M	571K	1.68M	1.09M	700K	271K	24K	867M	766M
Stock-Based Compensation	45.86M	19.97M	15.18M	17.54M	6.59M	26K	1K	n/a	n/a
Other Working Capital	-10.54M	3.34M	-4.14M	-4.45M	-3.46M	-284K	-34K	-1.71B	658M
Other Non-Cash Items	607K	929K	2.97M	-746K	514K	1.32M	21K	584M	136M
Deferred Income Tax	n/a	n/a	n/a	2.59M	12K	n/a	n/a	610M	45M
Change in Working Capital	-19.49M	26.31M	-5.38M	9.26M	5.11M	1.41M	601K	-1.6B	938M
Operating Cash Flow	-292.37M	-188.16M	-153.65M	-119.56M	-46.51M	-11.83M	-4.16M	585M	676M
Capital Expenditures	-2.38M	-729K	-3.07M	-3.62M	-1.16M	-1.65M	-134K	-224M	-326M
Cash Acquisitions	n/a	n/a	34K	8K	n/a	n/a	n/a	-3.32B	n/a
Purchase of Investments	-317.44M	-44.26M	-121.18M	-236.72M	-44.5M	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	115.71M	128.3M	211.44M	102.45M	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	35K	1.00	-34K	-8K	-44.5M	n/a	n/a	784M	-1.82B
Investing Cash Flow	-204.08M	83.31M	87.2M	-137.89M	-45.66M	-1.65M	-134K	-2.76B	-2.15B
Debt Repayment	n/a	n/a	n/a	n/a	-64K	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	36.84M	1.95M	529K	584K	-420K	n/a	5M	-1.3B	2.74B
Financial Cash Flow	809.89M	54.32M	37.39M	157.82M	380.69M	19.99M	12.42M	-1.3B	2.74B
Net Cash Flow	313.45M	-50.52M	-29.05M	-99.63M	288.52M	6.51M	12.42M	-3.47B	1.27B
Free Cash Flow	-294.75M	-188.89M	-156.71M	-123.18M	-47.67M	-13.48M	-4.3M	361M	350M